TrialDrug design, development and therapy2013

Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.

Konstantinos Zarogoulidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.